Innoviva (INVA)

• Market cap: $1.63B
• 1 day: -0.41%
• 5 days: -0.94%
• 1 month: -7.51%
• 3 months: 10.02%
• 6 months: 13.83%
• Year to date: 11.02%
• 1 year: 25.84%
• 5 years: 79.79%
• 10 years: 97.67%
• Sector: Healthcare
• Industry: Biotechnology

About: Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Employees: 159